| Name | Title | Contact Details |
|---|
Nekoosas mission is to manufacture and convert the highest quality specialty print media substrates for the commercial print and graphics markets. The partnership of Nekoosa Coated Products, RTape, Catalina Graphic Films and CET Films allows Nekoosa to deliver excellence across its product portfolio and create new opportunities for our customers. Nekoosas strong legacy of manufacturing and converting specialty products began over 60 years ago as a division of 3M. Nekoosa has since evolved into a key supplier of visual communication products including wide and grand format rolls; offset, screen, HP Indigo and dry toner sheets; cut films; application tapes and premasks; carbonless papers and extruded films. The simple mission statement that guides us is, ‘Whats New…". We pride ourselves in being ‘different, which means we are energetic, innovative and take a sustainable approach to ensure that everything we do leaves a positive impact on our team members, customers and communities.
Northern Capital Insurance is a Minneapolis, MN-based company in the Business Services sector.
Torvec is a publicly owned development stage automotive technology company based in Rochester, NY.
The Les Turner ALS Foundation is a non-profit organization based in Chicago that provides ALS patient services; supports events, education and awareness about ALS; and funds ALS research.
AVITA Medical (NASDAQ: RCEL, ASX:AVH) is a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patients own skin to create Spray-On Skin™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm®, a Biosynthetic Wound Matrix, in the United States.